Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.Biodel Inc • December 14th, 2009 • Pharmaceutical preparations
Based upon recent discussions between Biodel and Organon it is understood that both parties desire to extend the current Supply Agreement as described below. Biodel requests a modification to the Supply Agreement such that the Fixed Quarterly Quantities of the Product to be delivered in calendar year 2010, as referred to in article 4.1 of the Supply Agreement, are reduced to the following: [**] in Q1, [**] in Q2, [**] in Q3 and [**] in Q4.
